We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Second and subsequent lines of chemotherapy for metastatic breast cancer: what did we learn in the last two decades?
- Authors
Cardoso, F; Di, Leo A; Lohrisch, C; Bernard, C; Ferreira, F; Piccart, M J
- Abstract
Despite almost 30 years of clinical cancer research, the true impact of second and subsequent lines of chemotherapy on the outcome of metastatic breast cancer patients, especially on the duration of survival, is still unknown. In the virtually incurable metastatic setting, issues like quality of life and patients' preferences gain particular relevance. At the turn of the century, in-depth rethinking of the design of clinical trials run in this challenging disease setting appears to be warranted.
- Publication
Annals of oncology : official journal of the European Society for Medical Oncology, 2002, Vol 13, Issue 2, p197
- ISSN
0923-7534
- Publication type
Journal Article
- DOI
10.1093/annonc/mdf101